Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$0.77 - $1.16 $5,185 - $7,811
-6,734 Reduced 37.86%
11,053 $8,000
Q2 2022

Aug 12, 2022

SELL
$1.47 - $2.94 $51,278 - $102,556
-34,883 Reduced 66.23%
17,787 $28,000
Q1 2022

May 13, 2022

BUY
$2.72 - $5.97 $7,616 - $16,716
2,800 Added 5.61%
52,670 $156,000
Q4 2021

Feb 09, 2022

BUY
$5.17 - $8.65 $177,362 - $296,746
34,306 Added 220.42%
49,870 $281,000
Q3 2021

Nov 12, 2021

BUY
$4.2 - $11.92 $65,368 - $185,522
15,564 New
15,564 $115,000

About Edesa Biotech, Inc.


  • Ticker EDSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,462,300
  • Market Cap $38.2M
  • Description
  • Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...
More about EDSA
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.